X-Vax Technology Company
X-VAX is a biotech company committed to developing vaccines against pathogens acquired by mucosal infection such as herpes.
Headquarters:
Jupiter, Florida, United States
Last Funding Type:
Series A
Investors Number:
7
Last Funding Date:
2019
Employee Number:
11-50
Total Funding:
56000000
Founded Date:
2015
Estimated Revenue:
Less than $1M
Investor Type:
Early Stage Venture
Industry:
Biotechnology, Health Care, Medical